Reconstructing single-cell karyotype alterations in colorectal cancer identifies punctuated and gradual diversification patterns.


Journal

Nature genetics
ISSN: 1546-1718
Titre abrégé: Nat Genet
Pays: United States
ID NLM: 9216904

Informations de publication

Date de publication:
08 2021
Historique:
received: 08 03 2021
accepted: 24 05 2021
pubmed: 3 7 2021
medline: 11 9 2021
entrez: 2 7 2021
Statut: ppublish

Résumé

Central to tumor evolution is the generation of genetic diversity. However, the extent and patterns by which de novo karyotype alterations emerge and propagate within human tumors are not well understood, especially at single-cell resolution. Here, we present 3D Live-Seq-a protocol that integrates live-cell imaging of tumor organoid outgrowth and whole-genome sequencing of each imaged cell to reconstruct evolving tumor cell karyotypes across consecutive cell generations. Using patient-derived colorectal cancer organoids and fresh tumor biopsies, we demonstrate that karyotype alterations of varying complexity are prevalent and can arise within a few cell generations. Sub-chromosomal acentric fragments were prone to replication and collective missegregation across consecutive cell divisions. In contrast, gross genome-wide karyotype alterations were generated in a single erroneous cell division, providing support that aneuploid tumor genomes can evolve via punctuated evolution. Mapping the temporal dynamics and patterns of karyotype diversification in cancer enables reconstructions of evolutionary paths to malignant fitness.

Identifiants

pubmed: 34211178
doi: 10.1038/s41588-021-00891-2
pii: 10.1038/s41588-021-00891-2
pmc: PMC8346364
doi:

Substances chimiques

Chromatin 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

1187-1195

Subventions

Organisme : NCI NIH HHS
ID : U54 CA217376
Pays : United States
Organisme : Cancer Research UK
ID : A19771
Pays : United Kingdom
Organisme : Cancer Research UK
ID : A22909
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 202778/Z/16/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 097319/Z/11/Z
Pays : United Kingdom

Informations de copyright

© 2021. The Author(s).

Références

Taylor, A. M. et al. Genomic and functional approaches to understanding cancer aneuploidy. Cancer Cell 33, 676–689.e3 (2018).
doi: 10.1016/j.ccell.2018.03.007
Priestley, P. et al. Pan-cancer whole-genome analyses of metastatic solid tumours. Nature 575, 210–216 (2019).
doi: 10.1038/s41586-019-1689-y
Watkins, T. B. K. et al. Pervasive chromosomal instability and karyotype order in tumour evolution. Nature https://doi.org/10.1038/s41586-020-2698-6 (2020).
Laks, E. et al. Clonal decomposition and DNA replication states defined by scaled single-cell genome sequencing. Cell 179, 1207–1221.e22 (2019).
doi: 10.1016/j.cell.2019.10.026
Navin, N. et al. Tumour evolution inferred by single-cell sequencing. Nature 472, 90–94 (2011).
doi: 10.1038/nature09807
Zahir, N., Sun, R., Gallahan, D., Gatenby, R. A. & Curtis, C. Characterizing the ecological and evolutionary dynamics of cancer. Nat. Genet. 52, 759–767 (2020).
doi: 10.1038/s41588-020-0668-4
Bolhaqueiro, A. C. F. et al. Ongoing chromosomal instability and karyotype evolution in human colorectal cancer organoids. Nat. Genet. 51, 824–834 (2019).
doi: 10.1038/s41588-019-0399-6
Davis, A., Gao, R. & Navin, N. Tumor evolution: linear, branching, neutral or punctuated. Biochim. Biophys. Acta Rev. Cancer 1867, 151–161 (2017).
doi: 10.1016/j.bbcan.2017.01.003
Turajlic, S., Sottoriva, A., Graham, T. & Swanton, C.Resolving genetic heterogeneity in cancer. Nat. Rev. Genet. 20, 404–416 (2019).
doi: 10.1038/s41576-019-0114-6
Notta, F. et al. A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns. Nature 538, 378–382 (2016).
doi: 10.1038/nature19823
Field, M. G. et al. Punctuated evolution of canonical genomic aberrations in uveal melanoma. Nat. Commun. 9, 116 (2018).
doi: 10.1038/s41467-017-02428-w
Baca, S. C. et al. Punctuated evolution of prostate cancer genomes. Cell 153, 666–677 (2013).
doi: 10.1016/j.cell.2013.03.021
Gao, R. et al. Punctuated copy number evolution and clonal stasis in triple-negative breast cancer. Nat. Genet. 48, 1119–1130 (2016).
doi: 10.1038/ng.3641
Sun, R., Hu, Z. & Curtis, C. Big bang tumor growth and clonal evolution. Cold Spring Harb. Perspect. Med. https://doi.org/10.1101/cshperspect.a028381 (2018).
Van de Wetering, M. et al. Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell 161, 933–945 (2015).
doi: 10.1016/j.cell.2015.03.053
Lo, Y., Karlsson, K. & Kuo, C. J. Applications of organoids for cancer biology and precision medicine. Nat. Cancer 1, 761–773 (2020).
doi: 10.1038/s43018-020-0102-y
Vlachogiannis, G. et al. Patient-derived organoids model treatment response of metastatic gastrointestinal cancers. Science 359, 920–926 (2018).
doi: 10.1126/science.aao2774
Gerlinger, M. et al. Cancer: evolution within a lifetime. Annu. Rev. Genet. 48, 215–236 (2014).
doi: 10.1146/annurev-genet-120213-092314
Markowetz, F. A saltationist theory of cancer evolution. Nat. Genet. 48, 1102–1103 (2016).
doi: 10.1038/ng.3687
Laughney, A. M., Elizalde, S., Genovese, G. & Bakhoum, S. F. Dynamics of tumor heterogeneity derived from clonal karyotypic evolution. Cell Rep. 12, 809–820 (2015).
doi: 10.1016/j.celrep.2015.06.065
Zhang, C. Z. et al. Chromothripsis from DNA damage in micronuclei. Nature 522, 179–184 (2015).
doi: 10.1038/nature14493
Gurskaya, N. G. et al. Engineering of a monomeric green-to-red photoactivatable fluorescent protein induced by blue light. Nat. Biotechnol. 24, 461–465 (2006).
doi: 10.1038/nbt1191
Maciejowski, J., Li, Y., Bosco, N., Campbell, P. J. & de Lange, T. Chromothripsis and kataegis induced by telomere crisis. Cell 163, 1641–1654 (2015).
doi: 10.1016/j.cell.2015.11.054
Chen, X. et al. In trans paired nicking triggers seamless genome editing without double-stranded DNA cutting. Nat. Commun. 8, 657 (2017).
doi: 10.1038/s41467-017-00687-1
Umbreit, N. T. et al. Mechanisms generating cancer genome complexity from a single cell division error. Science https://doi.org/10.1126/science.aba0712 (2020).
Soto, M., Garcia-Santisteban, I., Krenning, L., Medema, R. H. & Raaijmakers, J. A. Chromosomes trapped in micronuclei are liable to segregation errors. J. Cell Sci. https://doi.org/10.1242/jcs.214742 (2018).
Terradas, M., Martin, M. & Genesca, A. Impaired nuclear functions in micronuclei results in genome instability and chromothripsis. Arch. Toxicol. 90, 2657–2667 (2016).
doi: 10.1007/s00204-016-1818-4
Crasta, K. et al. DNA breaks and chromosome pulverization from errors in mitosis. Nature 482, 53–58 (2012).
doi: 10.1038/nature10802
Liu, S. et al. Nuclear envelope assembly defects link mitotic errors to chromothripsis. Nature 561, 551–555 (2018).
doi: 10.1038/s41586-018-0534-z
Hatch, E. M., Fischer, A. H., Deerinck, T. J. & Hetzer, M. W. Catastrophic nuclear envelope collapse in cancer cell micronuclei. Cell 154, 47–60 (2013).
doi: 10.1016/j.cell.2013.06.007
Maiato, H. & Logarinho, E. Mitotic spindle multipolarity without centrosome amplification. Nat. Cell Biol. 16, 386–394 (2014).
doi: 10.1038/ncb2958
Godinho, S. A., Kwon, M. & Pellman, D. Centrosomes and cancer: how cancer cells divide with too many centrosomes. Cancer Metastasis Rev. 28, 85–98 (2009).
doi: 10.1007/s10555-008-9163-6
Bielski, C. M. et al. Genome doubling shapes the evolution and prognosis of advanced cancers. Nat. Genet. 50, 1189–1195 (2018).
doi: 10.1038/s41588-018-0165-1
Cernat, L. et al. Colorectal cancers mimic structural organization of normal colonic crypts. PLoS ONE 9, e104284 (2014).
doi: 10.1371/journal.pone.0104284
Lee-Six, H. et al. The landscape of somatic mutation in normal colorectal epithelial cells. Nature 571, 532–537 (2019).
doi: 10.1038/s41586-019-1672-7
Sottoriva, A. et al. A Big Bang model of human colorectal tumor growth. Nat. Genet. 47, 209–216 (2015).
doi: 10.1038/ng.3214
Koo, B. K. Generation of FLIP and FLIP-FlpE targeting vectors for biallelic conditional and reversible gene knockouts in mouse and human cells. Methods Mol. Biol. 1842, 255–264 (2018).
doi: 10.1007/978-1-4939-8697-2_19
Fujii, M., Matano, M., Nanki, K. & Sato, T. Efficient genetic engineering of human intestinal organoids using electroporation. Nat. Protoc. 10, 1474–1485 (2015).
doi: 10.1038/nprot.2015.088
Drost, J. et al. Sequential cancer mutations in cultured human intestinal stem cells. Nature 521, 43–47 (2015).
doi: 10.1038/nature14415
Verissimo, C. S. et al. Targeting mutant RAS in patient-derived colorectal cancer organoids by combinatorial drug screening. eLife https://doi.org/10.7554/eLife.18489 (2016).
Cross, W. et al. Stabilising selection causes grossly altered but stable karyotypes in metastatic colorectal cancer. Preprint at bioRxiv https://doi.org/10.1101/2020.03.26.007138 (2020).
Swennenhuis, J. F. Unmasking Circulating Tumor Cells. PhD thesis, Univ. Twente (2017).
Garvin, T. et al. Interactive analysis and assessment of single-cell copy-number variations. Nat. Methods 12, 1058–1060 (2015).
doi: 10.1038/nmeth.3578
Williams, M. J. et al. Quantification of subclonal selection in cancer from bulk sequencing data. Nat. Genet. 50, 895–903 (2018).
doi: 10.1038/s41588-018-0128-6
Toni, T., Welch, D., Strelkowa, N., Ipsen, A. & Stumpf, M. P. Approximate Bayesian computation scheme for parameter inference and model selection in dynamical systems. J. R. Soc. Interface 6, 187–202 (2009).
doi: 10.1098/rsif.2008.0172
François, O. & Laval, G. Deviance information criteria for model selection in approximate Bayesian computation. Stat. Appl. Genet. Mol. Biol. https://doi.org/10.2202/1544-6115.1678 (2011).

Auteurs

Yannik Bollen (Y)

Molecular Cancer Research, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Oncode Institute, Utrecht, the Netherlands.
Medical Cell Biophysics, TechMed Centre, University of Twente, Enschede, the Netherlands.

Ellen Stelloo (E)

Oncode Institute, Utrecht, the Netherlands.
Department of Genetics, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

Petra van Leenen (P)

Molecular Cancer Research, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Oncode Institute, Utrecht, the Netherlands.

Myrna van den Bos (M)

Molecular Cancer Research, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Oncode Institute, Utrecht, the Netherlands.

Bas Ponsioen (B)

Molecular Cancer Research, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Oncode Institute, Utrecht, the Netherlands.

Bingxin Lu (B)

Department of Cell and Developmental Biology, University College London, London, UK.
UCL Genetics Institute, University College London, London, UK.

Markus J van Roosmalen (MJ)

Department of Genetics, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

Ana C F Bolhaqueiro (ACF)

Oncode Institute, Utrecht, the Netherlands.
Hubrecht Institute, KNAW, Utrecht, the Netherlands.
University Medical Center Utrecht, Utrecht, the Netherlands.

Christopher Kimberley (C)

Centre for Genomics and Computational Biology, Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

Maximilian Mossner (M)

Centre for Genomics and Computational Biology, Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

William C H Cross (WCH)

Centre for Genomics and Computational Biology, Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
UCL Cancer Institute, UCL, London, UK.

Nicolle J M Besselink (NJM)

Oncode Institute, Utrecht, the Netherlands.
Department of Genetics, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

Bastiaan van der Roest (B)

Oncode Institute, Utrecht, the Netherlands.
Department of Genetics, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

Sander Boymans (S)

Oncode Institute, Utrecht, the Netherlands.
Department of Genetics, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

Koen C Oost (KC)

Molecular Cancer Research, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Oncode Institute, Utrecht, the Netherlands.

Sippe G de Vries (SG)

Molecular Cancer Research, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Oncode Institute, Utrecht, the Netherlands.

Holger Rehmann (H)

Molecular Cancer Research, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

Edwin Cuppen (E)

Oncode Institute, Utrecht, the Netherlands.
Department of Genetics, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Hartwig Medical Foundation, Amsterdam, the Netherlands.

Susanne M A Lens (SMA)

Molecular Cancer Research, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Oncode Institute, Utrecht, the Netherlands.

Geert J P L Kops (GJPL)

Oncode Institute, Utrecht, the Netherlands.
Hubrecht Institute, KNAW, Utrecht, the Netherlands.
University Medical Center Utrecht, Utrecht, the Netherlands.

Wigard P Kloosterman (WP)

Department of Genetics, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

Leon W M M Terstappen (LWMM)

Medical Cell Biophysics, TechMed Centre, University of Twente, Enschede, the Netherlands.

Chris P Barnes (CP)

Department of Cell and Developmental Biology, University College London, London, UK.
UCL Genetics Institute, University College London, London, UK.

Andrea Sottoriva (A)

Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.

Trevor A Graham (TA)

Centre for Genomics and Computational Biology, Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

Hugo J G Snippert (HJG)

Molecular Cancer Research, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. h.j.g.snippert@umcutrecht.nl.
Oncode Institute, Utrecht, the Netherlands. h.j.g.snippert@umcutrecht.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH